FDA 483 - Straight Arrow Products, Inc. - October 15, 2024

Straight Arrow Products, Inc. in Easton, PA, an OTC drug manufacturer, was cited for multiple significant deficiencies during an FDA inspection. The observations highlight severe issues across quality control, process validation, equipment maintenance, stability testing, computer system controls, and annual product reviews. These findings indicate a systemic failure to adhere to Good Manufacturing Practices.